HMGN1 has also been identified as a target of recurrent DNA copy increase in leukemia, and the mechanisms that combined HMGN1 overexpression and the AML-ETO9a fusion oncoprotein could hinder bone marrow differentiation and promote leukemic stem cell activity [33]. The gene discussed is HMGN1; the disease is acute myeloid leukemia.